SCHEMBL20150552

SCHEMBL20150552

COc1cccc(-n2nc3c4cc(C)ccc4[nH]cc-3c2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.44
▸ RECQL P46063 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ NPBWR1 P48145 2/20 0.41
▸ MCHR1 Q99705 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150512 0.91 ALDH1A1 (0.45) ALDH1A1NPSR1RECQLL3MBTL1NPBWR1
SCHEMBL20150565 0.90 NPBWR1 (0.43) ALDH1A1NPBWR1MCHR1KDM4EGAA
SCHEMBL20150514 0.89 PDE4B (0.43) ALDH1A1NPSR1L3MBTL1PDE4BNPBWR1
SCHEMBL18285396 0.88 KDM4E (0.49) ALDH1A1NPSR1RECQLL3MBTL1PDE4B
SCHEMBL1467162 0.86 GABRA1 (0.48) ALDH1A1PDE4BKDM4EGAALMNA
SCHEMBL20150536 0.85 L3MBTL1 (0.41) ALDH1A1NPSR1RECQLL3MBTL1KDM4E
SCHEMBL1467262 0.85 PDE4B (0.46) ALDH1A1PDE4BKDM4EPDGFRBLMNA
SCHEMBL18293344 0.85 ALDH1A1 (0.41) ALDH1A1NPSR1RECQLL3MBTL1NPBWR1
SCHEMBL20150531 0.85 ALDH1A1 (0.41) ALDH1A1NPSR1RECQLL3MBTL1PDE4B
SCHEMBL18285421 0.85 NPSR1 (0.39) ALDH1A1NPSR1RECQLL3MBTL1PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134698-A1 LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134698-A1 LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE GABRA6, HTR6, GABRD ALDH1A1 604/4885NPSR1 26/4885RECQL 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback